U.S. Markets close in 1 hr 45 mins

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
62.91+0.38 (+0.61%)
As of 2:14PM EST. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.74
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 372.50
52 Week Low 319.51
50-Day Moving Average 360.74
200-Day Moving Average 346.15

Share Statistics

Avg Vol (3 month) 31.67M
Avg Vol (10 day) 31.83M
Shares Outstanding 5102.29M
Float 99.93M
% Held by Insiders 12.63%
% Held by Institutions 167.10%
Shares Short (Nov 12, 2020) 48.2M
Short Ratio (Nov 12, 2020) 46.35
Short % of Float (Nov 12, 2020) 411.03%
Short % of Shares Outstanding (Nov 12, 2020) 48.01%
Shares Short (prior month Oct 14, 2020) 49.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Nov 16, 2011

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2020
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin -96.09%
Operating Margin (ttm)-105.87%

Management Effectiveness

Return on Assets (ttm)-13.35%
Return on Equity (ttm)-23.96%

Income Statement

Revenue (ttm)87.99M
Revenue Per Share (ttm)0.87
Quarterly Revenue Growth (yoy)-82.40%
Gross Profit (ttm)87.99M
EBITDA -87.22M
Net Income Avi to Common (ttm)-84.55M
Diluted EPS (ttm)-0.84
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)315.49M
Total Cash Per Share (mrq)3.07
Total Debt (mrq)21.14M
Total Debt/Equity (mrq)4.58
Current Ratio (mrq)7.92
Book Value Per Share (mrq)4.51

Cash Flow Statement

Operating Cash Flow (ttm)-95.39M
Levered Free Cash Flow (ttm)-78.67M